C18H16F3N3O2S
395.4 g/mol
APIDanger
2,5-dimethylcelecoxib
CAS457639-26-8
Category
API
Compound Class
Heterocycle
Primary Use
Pharmaceutical Raw Material
2,5-dimethylcelecoxib is an organic molecular entity that functions as a geroprotector research compound. It is a non-COX-2 inhibitory structural analog of celecoxib, used in laboratory studies related to aging and geroprotection.
geroprotector research compoundnon-COX-2 inhibitory structural analog of celecoxib
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing 2,5-dimethylcelecoxib?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
Related Compounds
SimilarStructure SimilarSimilarity 0.77
4-Desmethyl-2-methyl Celecoxib
CAS170569-99-0
pharmaceutical intermediate
SimilarStructure SimilarSimilarity 0.73
Celecoxib
CAS169590-42-5
pharmaceutical raw material
ReferenceSame Category
Obeticholic acid
CAS459789-99-2
pharmaceutical raw material
ReferenceSame Category
Dapagliflozin
CAS461432-26-8
pharmaceutical raw material
ReferenceSame Category
Β-lactulose
CAS4618-18-2
pharmaceutical raw material
ReferenceSame Category
Nutriacholic acid
CAS4651-67-6
pharmaceutical raw material
Referencesame scaffold
CHEMBL29923
CAS170570-01-1
pharmaceutical raw material
Referencesame scaffold
Mavacoxib
CAS170569-88-7
pharmaceutical raw material
Safety Reference
Danger
H301Toxic if swallowed
Identifiers
IUPAC Name
4-[5-(2,5-dimethylphenyl)-3-(trifluoromethyl)pyrazol-1-yl]benzenesulfonamide
InChIKey
NTFOSUUWGCDXEF-UHFFFAOYSA-N
SMILES
CC1=CC(=C(C=C1)C)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F
Synonyms (12)
- 2,5-DimethylCelecoxib-d4
- 2,5-dimethyl Celecoxib, DMC
- 2,5-dimethylcelecoxib
- Dimethyl Celecoxib
Sourcing 2,5-dimethylcelecoxib?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.